Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors
We found no significant difference in pathological findings or 3-year allograft outcomes following KT from NAT-negative, NAT+, or CoV-COD donors. Despite modestly reduced eGFR for COV-COD on unadjusted analysis, kidneys from donors with a spectrum of COVID severities did not experience significantly poorer allograft outcomes over 3 years.
Authors
- NABIN SHRESTHA
- Christine E. Koval (ORCID: https://orcid.org/0000-0002-8196-2601)
- Leal Herlitz (ORCID: https://orcid.org/0000-0003-2665-8559)
- Mohamed Eltemamy (ORCID: https://orcid.org/0000-0003-2947-179X)
- Alvin Wee
- Emilio D. Poggio
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1111/tid.70202
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00